BEUDAMED
    FDA Adverse Event Malfunction Summary report: N

    ALERE DETERMINE HIV 1/2 AG/AB COMBO

    MDR report key: 7591049 · Received June 12, 2018

    Report

    Report Number
    1221359-2018-00321
    Event Type
    Malfunction
    Date Received
    June 12, 2018
    Date of Event
    August 12, 2017
    Report Date
    June 12, 2018
    Manufacturer
    ALERE SCARBOROUGH INC.
    Product Code
    MZF
    UDI-DI
    10811877010323
    PMA / PMN Number
    BP120037-0
    Product Problem
    Yes
    Report Source
    Manufacturer report
    Reporter Location
    DE, US
    Reporter Occupation
    OTHER

    Narratives

    Additional Manufacturer Narrative · 1

    THIS CASE WAS REGARDING AN EMPLOYEE WHO HAD AN EXPOSURE TO BLOOD PRODUCT FROM A SOURCE PATIENT WITH A REPORTED (B)(6) RESULT WITH THE ALERE DETERMINE HIV 1/2 AG/AB TEST. TESTING WAS PERFORMED ON RETAINED KIT LOT 090156 WITH THE FOLLOWING INTERNAL SERUM/PLASMA CONTROL SAMPLES: (B)(6). THE KIT PERFORMED AS EXPECTED. ADDITIONALLY, QC DATA AND BATCH RECORDS FOR LOT 090156 WERE REVIEWED. RELEASE TESTING WAS VALID AND THE LOT WAS FOUND TO BE PERFORMING AS EXPECTED. A REVIEW OF THE COMPLAINTS REPORTED (B)(6) RELATED TO LOT NUMBER 090156 SHOWED THAT THE COMPLAINT RATE IS (B)(4). THE EVIDENCE AVAILABLE DOES NOT INDICATE THAT THE PRODUCT IS PERFORMING OUTSIDE LABEL CLAIMS. IN HOUSE TESTING WAS UNABLE TO DETERMINE THE EXACT ROOT CAUSE OF THE REPORTED ISSUE. THE RESULTS OBTAINED MAY POSSIBLY BE RELATED TO THE PATIENT SAMPLE. THE SAMPLE MAY HAVE CONTAINED SPECIFIC SUBSTANCES WHICH MAY HAVE AFFECTED THE RESULTS. THE AVAILABLE EVIDENCE SUGGESTS THAT THIS DEVICE LOT IS PERFORMING WITHIN LABELED CLAIMS.

    Description of Event or Problem · 1

    CUSTOMER REPORTED THAT AN EMPLOYEE WAS EXPOSED TO BLOOD PRODUCT FROM A SOURCE PATIENT WITH A (B)(6) RESULT ON A (B)(6) TESTED WITH THE ALERE DETERMINE HIV 1/2 AG/AB COMBO. THE EXPOSED EMPLOYEE WAS NOT TESTED WITH ALERE DETERMINE HIV 1/2 AG/AB COMBO. THE EMPLOYEE WAS STARTED ON (B)(6) AS A RESULT OF THE PRELIMINARY(B)(6) RESULT FROM THE SOURCE PATIENT. EMPLOYEE GENDER, PREGNANCY STATUS, AND OUTCOME WERE UNKNOWN. THERE IS INSUFFICIENT INFORMATION TO DETERMINE IF A MALFUNCTION OCCURRED. AT THE TIME OF THE EVENT THERE WAS NO INDICATION OF A PRODUCT MALFUNCTION BASED ON THE INFORMATION PROVIDED AND ASSESSED BY (B)(4), INC.; HOWEVER, THIS MDR IS A RETROSPECTIVE FILING IN RESPONSE TO AN FDA OBSERVATION FROM AN FDA INSPECTION CONDUCTED FEBRUARY 26TH TO MARCH 2ND, 2018 AT ALERE (B)(4), INC. ((B)(4)).

    Devices

    Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
    435763 ALERE DETERMINE HIV 1/2 AG/AB COMBO IVD FOR HIV AG/AB MZF ALERE SCARBOROUGH INC. 090156 10811877010323

    Patients

    Seq Age Sex Outcome Treatment
    1